← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 6, 2017Last known activity
Apr 8, 2025
Timeline
2010s
- Jun 1, 2014
Atea Pharmaceuticals, Inc.— Founded
Drugs by trial phase (13 distinct, 26 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Recent trials (29)
- NCT06921941Lead sponsorPhase 1Apr 8, 2025
- NCT06356194Lead sponsorPhase 1Apr 15, 2024
- NCT05905497Lead sponsorPhase 1Apr 26, 2023
- NCT05905484Lead sponsorPhase 1Apr 25, 2023
- NCT05731843Lead sponsorPhase 1Jan 30, 2023
- NCT05724693Lead sponsorPhase 1Jan 30, 2023
- NCT05629962Lead sponsorPhase 3Nov 25, 2022
- NCT05618314Lead sponsorPhase 1Oct 17, 2022
- NCT05366439Lead sponsorPhase 1May 31, 2022
- NCT05466240Lead sponsorPhase 2Apr 29, 2022
- NCT05256732Lead sponsorPhase 1Feb 22, 2022
- NCT05137626Lead sponsorPhase 1Nov 30, 2021
- NCT05154123Lead sponsorPhase 1Nov 16, 2021
- NCT05004415Lead sponsorPhase 1Jul 28, 2021
- NCT04889040Lead sponsorPhase 3Apr 28, 2021
Details
- Founded
- Boston, MA, US Jun 1, 2014
- Last known activity
- Apr 8, 2025